NIH initiative to 'rigorously evaluate' benefits, harms of evolving cancer screening technologies

The prospect of screening for multiple cancer types simultaneously through a blood draw or other simple methods has generated tremendous excitement. Multicancer detection tests — often called liquid biopsies — measure circulating tumor cells, tumor DNA or other substances in the blood, urine or other body fluids that can identify the presence of cancer.

Related Keywords

Virginia ,United States ,Colorado ,North Carolina ,University Of North Carolina ,India ,Virginia Commonwealth University ,America ,Virginians ,American ,Henry Ford ,S Patrick Nana Sinkam ,Christine Neslund Dudas ,Alex Krist ,Daniels Reuland ,Mindy Valcarcel ,Lori Minasian ,Jeffreyk Lee ,Byjennifer Byrne ,Massey Comprehensive Cancer Center ,Clinical Laboratory Improvement Amendments ,University Of Colorado Cancer Center ,Department Of Defense Uniformed Services University ,Us Preventive Services Task ,Lineberger Comprehensive Cancer Center ,University Of North Carolina At Chapel Hill ,Fred Hutch Cancer Center ,Department Of Defense ,Kaiser Permanente School Of Medicine ,Henry Ford Health ,Kaiser Permanente Northern California Division Of Research ,Alliance For Oncology Clinical Trials ,Theranos Inc ,Sentara Health ,Washington University School Of Medicine ,Cancer Screening Research Network ,Department Of Veterans Affairs ,National Lung Screening Trial ,Michigan State University Health Sciences ,Services Task Force ,Cancer Moonshot ,Hutch Cancer Center ,Ford Health ,Permanente Northern California ,Kaiser Permanente Southern California ,Kaiser Permanente School ,Stephenson Cancer Center ,Oklahoma Health Sciences ,Colorado Cancer Center ,Comprehensive Cancer Center ,Chapel Hill ,Commonwealth University ,University School ,Veterans Affairs ,Defense Uniformed Services University ,Kaiser Permanente Northern California Division ,Silicon Valley ,Oncology Clinical Trials ,African American ,Patrick Nana Sinkam ,